John Kao Sells 385,270 Shares of Alignment Healthcare (NASDAQ:ALHC) Stock

by · The Markets Daily

Alignment Healthcare, Inc. (NASDAQ:ALHC – Get Free Report) CEO John Kao sold 385,270 shares of the company’s stock in a transaction on Friday, September 11th. The stock was sold at an average price of $12.68, for a total transaction of $4,885,223.60. Following the transaction, the chief executive officer owned 1,223,473 shares of the company’s stock, valued at $15,513,637.64. This trade represents a 23.95% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Alignment Healthcare Price Performance

Shares of NASDAQ ALHC traded down $0.15 during mid-day trading on Friday, hitting $12.61. 6,075,652 shares of the stock traded hands, compared to its average volume of 3,839,666. The company has a debt-to-equity ratio of 1.22, a current ratio of 1.70 and a quick ratio of 1.70. Alignment Healthcare, Inc. has a twelve month low of $12.39 and a twelve month high of $25.12. The company has a market cap of $2.62 billion, a PE ratio of 66.37 and a beta of 1.11. The firm has a 50 day simple moving average of $16.17 and a two-hundred day simple moving average of $18.03.

Alignment Healthcare (NASDAQ:ALHC – Get Free Report) last issued its earnings results on Thursday, July 30th. The company reported $0.17 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.13 by $0.04. Alignment Healthcare had a return on equity of 20.02% and a net margin of 0.89%.The business had revenue of $1.34 billion during the quarter, compared to analysts’ expectations of $1.31 billion. During the same quarter in the prior year, the firm earned $0.07 EPS. The business’s revenue for the quarter was up 31.6% compared to the same quarter last year. As a group, equities research analysts forecast that Alignment Healthcare, Inc. will post 0.17 EPS for the current fiscal year.

Analysts Set New Price Targets

Several equities analysts have issued reports on ALHC shares. Weiss Ratings restated a “hold (c-)” rating on shares of Alignment Healthcare in a research report on Tuesday, August 4th. Wall Street Zen cut shares of Alignment Healthcare from a “buy” rating to a “hold” rating in a research note on Saturday, August 1st. Zacks Research cut Alignment Healthcare from a “strong-buy” rating to a “hold” rating in a research note on Monday, July 6th. Raymond James Financial lowered shares of Alignment Healthcare from a “strong-buy” rating to an “outperform” rating and lowered their price target for the stock from $22.00 to $19.00 in a report on Monday, August 3rd. Finally, JPMorgan Chase & Co. dropped their target price on shares of Alignment Healthcare from $26.00 to $22.00 and set an “overweight” rating on the stock in a report on Tuesday, August 4th. Seven investment analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $23.60.

View Our Latest Stock Analysis on Alignment Healthcare

Institutional Investors Weigh In On Alignment Healthcare

A number of hedge funds have recently added to or reduced their stakes in the business. Summit Securities Group LLC acquired a new stake in shares of Alignment Healthcare during the 4th quarter worth approximately $26,000. Versant Capital Management Inc lifted its position in shares of Alignment Healthcare by 463.3% during the 2nd quarter. Versant Capital Management Inc now owns 1,380 shares of the company’s stock valued at $33,000 after acquiring an additional 1,135 shares during the period. Parallel Advisors LLC lifted its position in shares of Alignment Healthcare by 87.7% during the 4th quarter. Parallel Advisors LLC now owns 1,654 shares of the company’s stock valued at $33,000 after acquiring an additional 773 shares during the period. Larson Financial Group LLC bought a new position in Alignment Healthcare during the third quarter worth $33,000. Finally, Nykredit A S bought a new position in Alignment Healthcare during the second quarter worth $36,000. 86.19% of the stock is currently owned by institutional investors.

Alignment Healthcare Company Profile

(Get Free Report)

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.

Featured Articles